Cheng Mo相关文献与解析，生知库 | 链接生命科学的每一步

Pan-cancer bone metastasis atlas at single-cell resolution identifies a distinct tumor-associated macrophage subset for mediating Denosumab-induced immunosensitization in lung cancer bone metastasis.

单细胞分辨率的泛癌骨转移图谱确定了一种独特的肿瘤相关巨噬细胞亚群，该亚群介导了地诺单抗诱导的肺癌骨转移免疫敏感性。

期刊:International Journal of Biological Sciences

doi:10.7150/ijbs.119777

Hu Xianglin, Du Nan, Song Yansha, Lang Ke, Tong Wanning, Ye Qingrong, Liu Xuesi, Zheng Haoyu, Cheng Mo, Ji Yingzheng, Wu Haibo, Zhang Minghe, He Xinhong, Zhang Yan, Li Xiaomeng, Zhu Yao, Li Kun, Cai Weiluo, Yan Wangjun, Huang Wending

Real-world study of adverse events associated with ceftazidime/avibactam based on the U.S. Food and Drug Administration adverse event reporting system database

基于美国食品药品监督管理局不良事件报告系统数据库，对头孢他啶/阿维巴坦相关不良事件进行真实世界研究

期刊:Frontiers in Cellular and Infection Microbiology

影响因子:4.8

doi:10.3389/fcimb.2026.1698293

Zheng, Xin; Peng, Yang; Ou, Yang-Xue; You, Bi-Bo; Zhang, Lu; Cheng, Yuan; Cheng, Mo; Xiang, Pu

发表日期：2026

文献求助收藏

C-C motif receptor 2 is a core profibrotic factor in uremic cardiomyopathy.

CC 基序受体 2 是尿毒症心肌病的核心促纤维化因子。

期刊:Disease Models & Mechanisms

影响因子:3.3

doi:10.1242/dmm.052395

Bao Jing-Fu, Guo Bao-Cheng, Mo Jia-Ju, Zhu Hongguo, Jia Nan, Hou Fanfan, Liu Youhua, Li Aiqing

CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial

CapeOX（卡培他滨和奥沙利铂）联合信迪利单抗和贝伐单抗生物类似药（IBI305）一线治疗晚期胃癌或食管胃交界处腺癌：一项单臂Ib/II期试验的研究方案

期刊:BMJ Open

影响因子:2.3

doi:10.1136/bmjopen-2024-086005

Dai, Ruihong; Zhang, Pengfei; Cheng, Mo; Bi, Feng; Zhou, Jitao; Liu, Ming

Pazopanib combined with doxorubicin and cisplatin in recurrent osteosarcoma: A retrospective cohort study

帕唑帕尼联合多柔比星和顺铂治疗复发性骨肉瘤：一项回顾性队列研究

期刊:Medicine

影响因子:1.4

doi:10.1097/MD.0000000000046576

Cai, Wei-Luo; Cheng, Mo; Sun, Zheng-Wang; Fang, Meng; Yan, Wang-Jun; Chen, Xiong-Sheng; Jiao, Gen-Long

骨肉瘤

发表日期：2026

文献求助收藏

Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report

高压氧疗法作为晚期胃肝样腺癌的免疫增敏策略：病例报告

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1625273

Li, Wenke; Wei, Jing; Zhang, Pengfei; Cheng, Mo; Xu, Menghui; Zhu, Lin; Liu, Ming

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial

XELOX联合信迪利单抗和高压氧疗法治疗晚期或转移性胃/胃食管交界处腺癌：一项前瞻性、单臂、Ib/II期临床试验的研究方案

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1672725

Li, Wenke; Zhang, Pengfei; Cheng, Mo; Wei, Jing; Xu, Menghui; Li, Dan; Song, Sihui; Liu, Ming; Huang, Cheng; Zhu, Lin

MET inhibitors as salvage therapy for MET-amplified gastric cancer with pulmonary lymphangitis

MET抑制剂作为MET扩增型胃癌合并肺淋巴管炎的挽救治疗

期刊:Precision Clinical Medicine

影响因子:5

doi:10.1093/pcmedi/pbae035

Zheng, Xiufeng; Cheng, Mo; Li, Wenke; Liu, Ming

Structural Insights Into the Role of RxLR Effectors in the Arms Race Between Oomycetes and Plants

从结构角度揭示RxLR效应蛋白在卵菌与植物军备竞赛中的作用

期刊:Molecular Plant Pathology

影响因子:4.9

doi:10.1111/mpp.70138

Liu, Yang; Zheng, Yang Yang; Zhou, Xin Ru; Ghanizadeh, Hossein; Wang, Dong Li; Wang, Pei Wen; Cheng, Mo Zhen; Liu, Jia Yin; Chen, Xiu Ling; Zhang, Y; Liu, Jun Feng; Wang, Ao Xue

发表日期：2025

文献求助收藏

Osteoimmunology uncovered: How macrophages and biomaterials revolutionize bone healing

骨免疫学揭秘：巨噬细胞和生物材料如何革新骨愈合

Pan-cancer bone metastasis atlas at single-cell resolution identifies a distinct tumor-associated macrophage subset for mediating Denosumab-induced immunosensitization in lung cancer bone metastasis.

单细胞分辨率的泛癌骨转移图谱确定了一种独特的肿瘤相关巨噬细胞亚群，该亚群介导了地诺单抗诱导的肺癌骨转移免疫敏感性。

Real-world study of adverse events associated with ceftazidime/avibactam based on the U.S. Food and Drug Administration adverse event reporting system database

基于美国食品药品监督管理局不良事件报告系统数据库，对头孢他啶/阿维巴坦相关不良事件进行真实世界研究

C-C motif receptor 2 is a core profibrotic factor in uremic cardiomyopathy.

CC 基序受体 2 是尿毒症心肌病的核心促纤维化因子。

CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial

CapeOX（卡培他滨和奥沙利铂）联合信迪利单抗和贝伐单抗生物类似药（IBI305）一线治疗晚期胃癌或食管胃交界处腺癌：一项单臂Ib/II期试验的研究方案

Pazopanib combined with doxorubicin and cisplatin in recurrent osteosarcoma: A retrospective cohort study

帕唑帕尼联合多柔比星和顺铂治疗复发性骨肉瘤：一项回顾性队列研究

Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report

高压氧疗法作为晚期胃肝样腺癌的免疫增敏策略：病例报告

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial

XELOX联合信迪利单抗和高压氧疗法治疗晚期或转移性胃/胃食管交界处腺癌：一项前瞻性、单臂、Ib/II期临床试验的研究方案

MET inhibitors as salvage therapy for MET-amplified gastric cancer with pulmonary lymphangitis

MET抑制剂作为MET扩增型胃癌合并肺淋巴管炎的挽救治疗

Structural Insights Into the Role of RxLR Effectors in the Arms Race Between Oomycetes and Plants

从结构角度揭示RxLR效应蛋白在卵菌与植物军备竞赛中的作用